A n atheroprotective effect of estrogen therapy in healthy postmenopausal women has been suggested by several studies. 1, 2 Although most actions of estrogen are receptordependent, nongenomic effects may also be important. Thus, 17␤-estradiol (E 2 ) has antioxidant effects in isolated microsomes and protects neurons from oxidative stress, and E 2 or 17␣-estradiol (17␣-E 2 ) can be effective in physiological doses. [3] [4] [5] Furthermore, estradiol inhibits LDL peroxidation in postmenopausal women. 6 The antioxidant effect of estradiol in neurons and lipid membranes appears to be dependent on the presence of the hydroxyl group in the C3 position of the A-ring of the steroid molecule. 5 Human cytomegalovirus (CMV) may contribute to the development and progression of atherosclerosis. 7 We previously detected accumulated amounts of the tumor suppressor protein p53 in human coronary artery smooth muscle cells (SMCs) of restenosis atherectomies, which correlated with the presence of intracellular CMV. 8 We further demonstrated that CMV infects SMCs and initiates viral replication, with generation of reactive oxygen species (ROSs). 9 ROSs are important for activation of NF-B, 10 a transcription factor that initiates expression of CMV proteins such as IE72 and IE84, and of mediators of inflammation such as intercellular adhesion molecule-1 (ICAM-1). 11 CMV infection causes release of arachidonic acid, stimulation of xanthine/xanthine oxidase, 9 and calcium influx, which contribute to ROS generation.
Because of the known effects of lipid and neuronal antioxidant properties and of reported interaction with calcium and cAMP, we asked whether estradiol might have effects with regard to ROS generation and cAMP activation and thereby inhibit viral and cellular gene expression. The partial estrogen antagonist tamoxifen has been shown to have lipid membrane antioxidant effects by decreasing membrane fluidity 4 and by inhibiting protein kinase (PK) C␣, 12 an activator of NF-B. Because interaction of CMV particles with the cell membrane leads to activation of PKC, 13 tamoxifen may interfere with CMV-dependent activation of the host cell by several mechanisms. Accordingly, we included tamoxifen, previously associated with reduced cardiovascular risk, in our experiments. 14 
Methods

Cells, Viruses, Plasmids, Antibodies, and Drugs
Human coronary SMCs (38-year-old female donor) and optimal medium (SmGM) including 5% FBS were purchased from Clonetics. Cells and virus (CMV, Towne strain) were grown as described elsewhere. 9 Virus and the plasmids pHD101CAT3 (MIEP-CAT), pRc/RSVIE72, and pRSVIE72 were gifts from E.S. Huang, University of North Carolina at Chapel Hill; 3X-B-CAT and 3X-mutB-CAT were gifts from A.S. Baldwin Jr, University of North Carolina at Chapel Hill; the ICAM-1 constructs (Ϫ277/ϩ1 and Ϫ182/ϩ1; the former contains an essential NF-B site, which is deleted in the latter) were gifts from S.W. Caughman, Emory University, Atlanta, Ga. 15 The following supplies were purchased: E 2 , 17␣-E 2 , 3-methoxyestrone (3-ME), and tamoxifen from Sigma; forskolin, (R)-p-adenosine-3Ј,5Ј-cyclic phosphorothioate (Rpiso), and the calcium ionophore A32187 from Calbiochem. The estrogen receptor (ER) inhibitor ICI 182,780 was kindly supplied by Zeneca Pharmaceuticals. Biotinylated ICAM-1 antibody was obtained from R&D Systems, and fluorescein-streptavidin and anti-streptavidin reagents were obtained from Vector Laboratories. Fluo 3-AM was obtained from Molecular Probes.
Assessment of H 2 O 2 -, CMV-, or cAMP-Dependent Intracellular Redox State
Generation of ROSs after administration of H 2 O 2 (200 nmol/L) to SMCs or during the first stages of CMV infection in SMCs was measured by use of 2N,7N-dichlorodihydrofluorescein diacetate (DCFH-DA; Molecular Probes). SMCs (passage 3) were grown in 4-well coverslips (Nunc) for 48 to 72 hours. HBSS containing H 2 O 2 freshly diluted from a 30% stock solution was added to SMCs for 10 minutes. Cells were washed twice with HBSS, and DCFH-DAcontaining HBSS was added. Preparations for fluorescence monitoring were done in the darkened microscopy room. Fluorescence was detectable after incubation with DCFH-DA for 5 minutes. One 4-well slide was processed at a time. Photomicrographs were collected within 10 minutes after addition of DCFH-DA. Fluorescence was quantified by confocal laser scanning microscopy (Leica TCS4D, Leica Lasertechnik). SMCs were grown in 4-well chamber slides for 72 hours and treated in serum-free and phenol red-free medium for 1 hour with one of the following: E 2 , 17␣-E 2 , 3-ME (each 0.1 to 10 nmol/L), or tamoxifen (50 to 500 nmol/L), and virus-containing medium was added for 1 hour. Free virus was then washed out with HBSS, and cells were treated with 5 mol/L DCFH-DA in HBSS and monitored under the microscope. Fluorescent signal was recorded and quantified by measurement of fluorescence intensity of 3 fields per well with computer software provided with the microscopy system. Results are tabulated as relative fluorescence units. Five experiments were performed. For intracellular cAMP assessment by enzyme immunoassay, SMCs were grown in 6-well plates at 4ϫ10 4 cells/well for 18 hours. SMCs in duplicate wells were treated with forskolin (5 mol/L), E 2 , or 17␣-E 2 (10 nmol/L), and then infected with CMV. Cells were washed, and 0.3 mL of ethanol was added per well at 0.5 hour and 1 hour. Supernatants were collected and evaporated in a Speedvac for 45 minutes, and residues were taken up into the reagent buffer specified by the instructions provided with the cAMP Bioassay kit (Amersham). Three experiments were performed.
Nuclear Extracts and Electrophoretic Mobility Shift Assay
SMCs were grown to 90% confluence in 175-cm 2 flasks. After removal of the medium, SMCs were pretreated for 1 hour as follows:
with serum-free medium and ethanol vehicle or with E 2 (1 and 10 nmol/L), 17␣-E 2 (10 nmol/L), and 3-ME (10 nmol/L). After 1 hour, the medium was renewed, and cells were infected for 1 hour with CMV at a multiplicity of infection (MOI) of 2. Cells were washed twice and harvested with a cell scraper, and nuclear extracts were prepared. For the duration of the experiment, cells were grown in 2% charcoal-adsorbed FBS (Cocalico Biologicals) to limit the hormone content of serum. Experiments were repeated twice with similar results. Double-stranded NF-B oligonucleotide probes were obtained commercially (Promega) and radiolabeled with [␥-32 P]ATP and T4 polynucleotide kinase.
Transfections and CAT Assays
SMCs were grown in optimal medium (5% FBS). For CAT assays, cells were seeded in 100-mm plates (1ϫ10 6 ) and transfected 20 hours later in serum-free SmGM with 0.1 g (per 3 mL total volume per dish) of MIEP-CAT. For cotransfections, we used 0.1 g MIEP-CAT plus 1 g pRc IE72; 1 g of 3X-B-CAT or 3X-mutB-CAT plus 0.5 g of the IE72; and 2 g ICAM-1-CAT or B-deleted ICAM-1-CAT plus increasing amounts of IE72. DOTAP (N-[1-(2,3-dioleoyloxy)-propyl]-N,N,N-trimethylammonium methyl sulfate; Boehringer Mannheim) lipofection agent was used as described before. 9 The assay was repeated twice.
Immunocytochemistry and Northern Blot Analysis for ICAM-1
For immunofluorescence assays, SMCs were infected as described above. Cells were fixed for 5 minutes in Ϫ10°C methanol exposed to biotinylated primary antibodies for 2 hours, then to fluorescein streptavidin and to anti-streptavidin antibodies for 1 hour. SMCs were then monitored under the laser scanning microscope. For Northern blotting, cells were grown to 80% confluence, and 1 flask 
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each was pretreated with E 2 or 3-ME (1 nmol/L), with N-acetylcysteine (NAC, 10 mmol/L, Sigma), or with vehicle for 1 hour in serum-free medium. CMV infection was performed as described above. SMCs were incubated with growth medium until harvested at 3 hours after infection by scraping into 15 mL Trizol (phenol and guanidine isothiocyanate, Gibco/BRL). The suspension was extracted with chloroform according to directions supplied with the reagent. Total RNA (15 to 20 g/lane) was resolved on a 1% agarose/formaldehyde gel and transferred overnight to nylon membranes. With ICAM-1 oligo-cocktail (R&D Systems) end-labeled with 32 P, 1ϫ10 7 cpm of probe was used for overnight (12 to 16 hours) hybridization at 42°C. Three experiments were performed, with similar results.
Immunoblotting
SMCs were pretreated for 1 hour with the estrogen compounds or tamoxifen and then infected with 2 MOI of CMV for 16 hours. Cells were then lysed, and equal aliquots of protein were subjected to SDS-PAGE as described in detail elsewhere. Whole-cell extracts were prepared for blotting with IE72 at 16 hours after CMV infection.
Figure 1.
SMCs were pretreated for 1 hour with indicated doses of E 2 , 17␣-E 2 (17a), 3-ME, or tamoxifen (TAM). Cells were then infected for 1 hour with CMV at 5 MOI, followed by addition of DCFH-DA fluorescent dye. Both stereoisomers of estradiol and tamoxifen, but not 3-ME, dose-dependently inhibited fluorescence, as determined by confocal laser microscopy. 
Viral Infectivity Assay and Cytopathic Effects
SMCs were infected with 5 MOI of CMV, as described before. Estrogen compounds, tamoxifen, ethanol vehicle, or medium was added to SMCs at 1 hour before infection. Free virus was then removed, cells were washed, and growth medium was added. The medium was renewed the next day and every 48 hours thereafter. Cytopathic effects and plaque formation were assessed at 3 to 5 days after infection by counting the number of foci (plaques) of infected cells exhibiting cytomegalic changes.
Cell Viability
After each experiment described above, SMCs were returned to the incubator for 3 to 7 days and monitored for cytopathic effects. Extra wells and dishes were prepared for cell counts and trypan blue exclusion. None of the treatments caused cell death.
Statistics
All experiments were performed in duplicate or triplicate with 3 to 6 separate SMC cultures, except for the immunoblots and Northern blots, which were performed twice from 2 separate cultures. Data are presented as mean؎SD. InStat3 software was used for calculation of probability values by 1-way ANOVA and for Tukey-Kramer multiple comparison test.
Results
Effects of Estrogen on ROS-Dependent Fluorescence
We examined the effect of estradiol on ROS generation by SMCs in response to exogenous H 2 O 2 (substrate for DCFH-DA) or to CMV infection. E 2 and its stereoisomer 17␣-E 2 dose-dependently inhibited ROS-dependent fluorescence in SMCs (0.1, 0.5, and 1.0 nmol/L), whether induced by exogenous H 2 O 2 (Table) or by CMV infection (Figure 1 , Table) . Similar inhibitory effects on ROS generation were seen with the partial ER antagonist tamoxifen (50 to 500 nmol/L), but not with 3-ME. Treatment with the ER inhibitor ICI 182,780 (1 mol/L) had little effect on reduction of fluorescence by E 2 (Table) . These data indicate that in SMCs, estradiol has dose-dependent and ER-independent inhibitory effects on ROSs derived from H 2 O 2 , the substrate for DCFH-DA. CMV infection causes cellular release of ROSs and arachidonic acid and stimulates PKC. 13 We also assessed the effects of E 2 on calcium by loading SMCs with the calciumspecific fluorescence probe fluo 3-AM. Intracellular calcium, depicted as fluo 3-AM fluorescence, was increased at 1 to 60 minutes after SMCs had been exposed to (1) 50 nmol/L calcium chloride in the presence of the ionophore A23187 and (2) CMV. E 2 inhibited calcium-dependent fluorescence in each case. ROSs can induce calcium overload, loss of cAMP, and smooth muscle contraction, and providing cAMP or antioxidants can restore cAMP-dependent PKA, which can counteract ROS-induced effects. 16 ,17 E 2 has been shown to Figure 4 . A, SMCs were cotransfected with 3XB-CAT reporter constructs and with IE72 expression vector. E 2 , 17␣-E 2 , and tamoxifen (TAM), but not 3-ME, inhibited IE72-induced activation of wild-type but not mutant 3XB-CAT reporter construct. B, In SMCs transfected with MIEP-CAT reporter, E 2 and TAM, but not 3-ME, inhibited IE72-induced activation of MIEP reporter. C, Forskolin (20 mol/L) or E 2 (10 nmol/L) decreases IE72-dependent NF-B-responsive transcription, and this decrease is relieved by Rpiso, an inhibitor of cAMP-dependent PKA. Three separate experiments were performed. *PϽ0.001. Figure 5 . Pretreatment of CMV-infected cells with E 2 (17␤E 2 ), 17␣-E 2 , or tamoxifen (TAM) decreased protein expression of CMV immediate early protein product and transcription activator IE72, as demonstrated by immunoblotting with an IE72-specific monoclonal antibody (6E1). 3-ME had no effect on IE72 expression.
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increase intracellular cAMP levels, 18 -21 and we found that treatment of CMV-infected cells with E 2 or 17␣-E 2 increased intracellular cAMP levels at 0.5 to 1 hour after infection. We used forskolin (5 mol/L), an adenylyl cyclase activator that increases PKA, as a positive control (Figure 2) . Increased cAMP has beneficial effects on calcium homeostasis and cellular redox state, and this could be one of the inhibitory mechanisms of E 2 on SMCs activated by CMV.
Estrogen and CMV-Induced Binding of NF-B
CMV has been shown to cause ROS generation, with subsequent activation and nuclear translocation of NF-B in a variety of cells. 9,10 Pretreatment of SMCs for 1 hour with 17␣-E 2 or E 2 , but not with 3-ME, caused a marked decrease in CMV-induced NF-B binding, as shown by electrophoretic mobility shift assay (Figure 3 ).
Estrogen and NF-B-Dependent Transcription
Because Treatment of transfected cells with forskolin plus Rpiso (10 mol/L, PKA inhibitor) or E 2 plus Rpiso partially relieved the inhibition. These findings indicate signaling between E 2 and cAMP that leads to anti-inflammatory effects in coronary SMCs. cAMP has been shown to interfere with NF-B-dependent transcription in human endothelial cells. 22 We now report that E 2 -induced cAMP reduces NF-Bdependent transcription in SMCs.
Estradiol Inhibits IE72 Protein Expression
Immunoblotting of lysates of CMV-infected cells with an IE72-specific antibody demonstrated that treatment with E 2 and 17␣-E 2 but not 3-ME reduced steady-state levels of IE72 protein at 16 hours after infection ( Figure 5 ). These experiments show that estradiol attenuates the expression of IE72. This blocking effect is due, at least in part, to the antioxidant and NFB-inhibitory effects of estradiol. Because IE72 is essential for the expression of the early and late genes of CMV, inhibition of IE72 effectively decreases viral productivity.
Estradiol Inhibits ICAM-1 Transcription and Protein Expression
CMV-IE72 transactivates the ICAM-1 promoter via the intact NF-B binding site, because deletion of this site results in lack of response ( Figure 6A ). As shown by Northern blotting, ICAM message was detectable at 3 hours after CMV infection of SMCs, whereas baseline (0 hours) mRNA was undetectable ( Figure 6B ). Pretreatment of SMCs with NAC (10 mmol/L) or with E 2 (10 nmol/L) reduced ICAM-1 mRNA, whereas 3-ME had little effect. Hybridization with the housekeeping gene glucose-3-phosphate-dehydrogenase confirmed both viability of the cells and equal sample loading. As seen by immunofluorescence, pretreatment with E 2 , but not with 3-ME, inhibits ICAM-1 protein expression at 24 hours after CMV infection ( Figure 6C ). These data indicate that E 2 attenuates CMV-induced ICAM-1 message by an antioxidant mechanism. This effect appears to be independent of ERs, because similar effects were obtained with 17␣-E 2 .
Viral Replication and Cytopathology
We next examined whether the inhibitory effect of estradiol on viral transcription and on expression of IE72 would affect viral replication. We infected SMCs with viral stock that had been treated with ethanol vehicle or with increasing concentrations of E 2 , 17␣-E 2 , 3-ME, or tamoxifen. Infection in untreated and vehicle-treated wells was similar. In contrast, E 2 and 17␣-E 2 , but not 3-ME, each inhibited viral infectivity in concentration-related fashion, and maximally (10 nmol/L) by 65%, and 5 mol/L tamoxifen reduced viral titer by 80% ( Figure 7 ). These data suggest that estradiol and tamoxifen attenuate CMV infectivity and cytopathic effects in human coronary SMCs.
Discussion
We have previously reported that infection of coronary artery SMCs with human CMV results in a rapid increase in ROSs. 9 Here we show that E 2 , at physiological concentrations, inhibits ROSs induced by H 2 O 2 or by CMV infection. E 2 also inhibits intracellular calcium after (1) uptake of exogenous calcium chloride in the presence of ionophore A23187 and (2) accumulation during CMV infection (Speir et al, unpublished observations) . Interestingly, in a recent report, sexspecific inhibition of calcium entry during vasoconstriction was E 2 -dependent. 23 In a reperfusion model with nanomolar E 2 plasma concentrations, E 2 diminished hydroxyl radical production. 24 In the present study, inhibition of ROSs by E 2 and 17␣-E 2 is probably due to antioxidant properties, because 3-ME, a related compound that lacks the phenolic group, does not reduce ROSs. These properties of E 2 and 17␣-E 2 are independent of ligand/receptor binding because (1) 26 Another finding is linked to E 2 antioxidant actions: E 2 and 17␣-E 2 stimulate intracellular cAMP (Figure 2 ), which inhibits NF-B-induced transcription ( Figure 4C ). The effects of E 2 on cAMP could account for important ER-independent mechanisms of gene activation. Effects via hypothetical membrane receptors have been reported, 18 -21 and our findings suggest that redox effects, perhaps relieving oxidative modification of cAMP-dependent PKA may play a role. In neurons, protective effects by E 2 have been linked to increases in cAMP levels, and this was inhibited by antagonists of cAMP/PKA, but not by the ER antagonist ICI 182,780, involving E 2 -binding sites that are distinct from both ER␣ and ER␤. 27 It is possible that SMCs express binding sites similar to those in neurons. However, our data suggest that E 2 increased cAMP levels by scavenging ROSs and subsequent protection of PKA from oxidation. Further experiments are needed to support this hypothesis.
We demonstrate that estradiol inhibits important steps of viral gene expression. Activation of the MIEP by mitogenic stimuli leads to expression within 3 to 4 hours of IE72, which transactivates the MIEP via NF-B binding sites. IE72 induction ensures expression of IE55 and IE84, and these 3 proteins induce transcription of p65 and p50, the major subunits of NF-B, which in turn activate the MIEP. 28 We show by transient transfection of SMCs that IE72 activates the MIEP, and E 2 , 17␣-E 2 , and tamoxifen, but not 3-ME, reduce this transcriptional activity partly by interfering with the DNA binding of NF-B. Because the MIEP contains sites for factors other than NF-B, we tested the effects of E 2 in SMCs transfected with IE72 and a reporter containing 3 NF-B elements only. As was true for MIEP activation, both stereoisomers of estradiol and tamoxifen, but not 3-methoxyestrone, blocked IE72-dependent B activity. Thus, estradiol inhibits NF-B-dependent activation by (1) reduced IE72 levels and subsequent reduced supply of the B subunit p65, (2) inhibition of NF-B by scavenging ROSs, and (3) augmentation of intracellular cAMP. In latently infected vascular cells, frequent abortive reactivation occurs, characterized by activation of the MIEP and expression of IE72, which activates the MIEP and ICAM. Thus, suppression of NF-B and IE72 prevents cell activation and progression of infection. As evidence for this, both stereoisomers of estradiol and tamoxifen, but not 3-methoxyestrone, reduced IE72 protein expression, viral titers, and cytopathic effects in SMCs. Our results suggest that estrogen treatment may inhibit viral and cellular inflammatory genes, which may contribute to atherogenesis in susceptible women.
